This site is intended for healthcare professionals only
LoginRegister
Lupin Manufacturing Solutions, PolyPeptide Group forge long term Peptide allianceBayer, Thermo Fisher Scientific join hands to increase patient access to precision cancer medicines
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreLonza to buy large-scale biologics Vacaville site from Roche for USD 1.2 billion
NPPA Finally Allows GSK to Discontinue Grisovin FPModify CT Protocol: CDSCO Panel Tells GSK on Respiratory Syncytial Virus(RSV) Vaccine
Pfizer Awards Rs 60 Lakh Each to 14 Healthtech Startups Under INDovation 2025Pfizer Gets CDSCO Panel Nod To study anti-cancer drug Lorlatinib
ZydusZydus Lifesciences receives tentative approval from USFDA for Letermovir Tablets
Novartis concludes acquisition of Tourmaline BioNovartis Fabhalta gets positive CHMP opinion as first oral monotherapy for adult patients with...
USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 CrGilead Sciences completes acquisition of CymaBay Therapeutics for USD 4.3 billion
Health Ministry Moves to Simplify Ethics Committee Registration Under NDCT RulesBill & Melinda Gates Medical Research Institute begins Phase 3 clinical trial of Tuberculosis...
Emcure Pharma Gets CDSCO Panel Nod to Conduct Phase IV Trial on Drospirenone TabletsConduct bioequivalence study: CDSCO Panel Tells Emcure Pharmaceutical on Ferric Maltol Capsules
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales WarningNovo Nordisk Awiqli recommended for approval for diabetes by European regulatory authorities
USFDA Approves Bionpharmas Generic HIV Drug EtravirineUSFDA grants full approval for Abbvie Elahere for certain ovarian cancer patients
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsJnJ gets USFDA nod for Opsynvi for chronic treatment of adults with pulmonary arterial hypertension
X